Epigenetic therapy shows promise against treatment-resistant AML

Medical Xpress

Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effective in treatment-resistant acute myeloid leukemia (AML) by activating the Hippo pathway, a tumor-suppressing pathway linked to cancer growth and drug resistance. ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

Epigenetic therapy shows promise against treatment-resistant AML

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Climate shocks are hitting South Africa's food businesses—study shows what they need to adapt

Chemists make elusive carbon-bridged sandwich molecule once thought too strained to exist

Microglia mechanism reveals why brain's stroke repair window closes

Medical Xpress의 다른 기사

Ureters stay visible for hours with dye designed to vanish through kidneys

Four ways to help your teen (and yourself) spend more time away from devices

Heat exposure during pregnancy and infancy may influence children's brain development